Skip to main content
UNIVERSAL BIOSENSORS INC. logo

UNIVERSAL BIOSENSORS INC. — Investor Relations & Filings

Ticker · UBI ISIN · AU000000UBI2 LEI · 9845006ABC71C514C696 ASX Manufacturing
Open in API
Filings indexed 958 across all filing types
Latest filing 2024-04-09 Declaration of Voting R…
Country AU Australia
Listing ASX UBI

About UNIVERSAL BIOSENSORS INC.

https://universalbiosensors.com/

Universal Biosensors Inc. specializes in the research, development, and manufacture of electrochemical biosensor systems for point-of-care testing. The company leverages a proprietary technology platform to deliver rapid, accurate diagnostic results across various sectors, including healthcare and food and beverage. Its core product offerings include the Xprecia Prime system for coagulation monitoring and the Sentia platform, which provides automated laboratory-grade analysis for the wine industry, measuring parameters such as free sulfur dioxide, malic acid, and glucose. Universal Biosensors focuses on miniaturizing complex laboratory tests into portable, easy-to-use devices, utilizing multi-layer test strip architecture and sophisticated electrochemical detection methods to improve testing efficiency and accessibility in decentralized settings.

Recent filings

Filing Released Lang Actions
Results of 2024 Special Meeting of Stockholders 2 pages 320.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the results of a special meeting of stockholders held on 10 April 2024. It details the voting outcomes on various resolutions, referencing the Proxy Statement dated 25 March 2024. The content focuses on the official voting results rather than the meeting materials or the proxy statement itself. The document is relatively short (3989 characters) and serves as an official notification of voting outcomes, which aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-04-09 English
Notice of Meeting/Proxy Statement 39 pages 1.3MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a definitive proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about the upcoming Annual General Meeting (AGM) of Universal Biosensors, Inc., including the date, time, virtual meeting details, proposals to be voted on (election of director, advisory vote on executive compensation), voting instructions, record date, and other proxy solicitation information. The document explicitly identifies itself as a Proxy Statement and contains no actual financial statements or earnings data. It also references the availability of the Annual Report (Form 10-K) but does not include it. The content aligns precisely with the definition of Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. Therefore, the correct classification is PSI with high confidence.
2024-04-08 English
Notice of Meeting of Stockholders on 10 April 2024 121 pages 1.6MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically titled as a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about a special meeting of stockholders, including proposals to be voted on, voting instructions, record dates, and other meeting logistics. The document is not an announcement of voting results but the solicitation material for voting. It contains detailed proxy solicitation information, proposals, and governance-related content. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the full proxy statement, not just a brief announcement or notice. Therefore, the correct classification is PSI with high confidence.
2024-03-25 English
Appendix 3Y - Craig Coleman 3 pages 222.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of shares and options held before and after the change, nature of the change, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 4257 characters, which is consistent with a detailed notice of director's interest changes rather than a brief announcement or a full financial report. Therefore, the correct classification is Director's Dealing (DIRS).
2024-03-25 English
Change in substantial holding 3 pages 326.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under Corporations Law Section 671B. It details changes in voting power and relevant interests of a substantial shareholder (Viburnum Funds Pty Ltd) in Universal Biosensors, Inc. It includes dates of changes, nature of changes, and associated parties. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory notice about shareholding changes.
2024-03-25 English
Application for quotation of securities - UBI 6 pages 19.1KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the securities to be quoted, issue dates, and related information about the securities issued as part of a previously announced transaction (referencing Appendix 3B). The document is a formal announcement related to the listing and quotation of new securities rather than a financial report, earnings release, or management discussion. It does not contain financial statements or management commentary but is focused on the capital market activity of securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement but a detailed application form for quotation of securities, consistent with SHA filings.
2024-03-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.